Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Blood|October 30, 2024
Current myeloproliferative neoplasm scoring systems for clinical practiceHélène Pasquer, Jean-Jacques Kiladjian, Lina BenajibaCancers|March 6, 2021
Descriptive and Functional Genomics in Acute Myeloid Leukemia (AML): Paving the Road for a CureHélène Pasquer, Maëlys Tostain, Nina Kaci, et al.The Oncologist|January 18, 2021
Can Some Anticancer Treatments Preserve the Ovarian Reserve?Nicolas Vallet, Nicolas Boissel, Elisabeth Elefant, et al.Molecular Cancer Therapeutics|April 19, 2024
INA03: A Potent Transferrin-Competitive Antibody-Drug Conjugate against CD71 for Safer Acute Leukemia TreatmentManuela Bratti, Elisa Stubbs, Sergii Kolodych, et al.EMBO Reports|June 11, 2025
AML patient blasts exhibit polarization defects upon interaction with bone marrow stromal cellsKhansa Saadallah, Benoît Vianay, Louise Bonnemay, et al.American Journal of Hematology|January 27, 2024
Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of MIPSS70+ v2.0 over MYSEC-PMMatteo Guerra, Hélène Pasquer, Rafael Daltro de Oliveira, et al.Leukemia|December 26, 2023
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratificationHélène Pasquer, Rafael Daltro de Oliveira, Loic Vasseur, et al.Nature Communications|July 7, 2025
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasmsNabih Maslah, Nina Kaci, Blandine Roux, et al.Hemasphere|September 8, 2025
Outcome of patients with accelerated and blast-phase myeloproliferative neoplasms not eligible for intensive chemotherapy or allogeneic hematopoietic cell transplantation treated by azacitidine alone or in combination-A FIM studyCorentin Orvain, Suzanne Tavitian, Clémence Mediavilla, et al.Nature Cancer|May 30, 2024
Targeting a lineage-specific PI3Kɣ-Akt signaling module in acute myeloid leukemia using a heterobifunctional degrader moleculeLois M Kelly, Justine C Rutter, Kevin H Lin, et al.Pageof 2